Per policy, these drugs may be converted from IV to PO in patients who meet criteria.
Generic (Brand)
Population
IV Dose
PO Dose
Notes
ciprofloxacin (Cipro)
adult
200 mg IV q12h
250 mg PO q12h
Avoid concurrent divalent and trivalent cation administration 2 hours before or 6 hours after. Avoid administration with tube feeds.
200 mg IV q24h
250 mg PO q24h
400 mg IV q8h
750 mg PO q12h
400 mg IV q12h
500 mg PO q12h
400 mg IV q24h
500 mg PO q24h
pediatric
10-15 mg/kg q8-12h (max: 400 mg/dose or 40 mg/kg/day)
10-15 mg/kg q8-12h (max: 750 mg/dose or 40 mg/kg/day)
Enteral Drug Administration notes.
Generic (Brand)
Comments and Considerations
Recommendations for Administration with Enteral Nutrition
ciprofloxacin (Cipro)
Binds to divalent ions (absorption reduced by 50%)
Recommend changing to IV for severe infections. For mild/moderate infections suggest 750 mg BID. Use crushed tablets (suspension may NOT be used with any feeding tube). Consider holding continuous EN for 1-2 hours before and after
2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults.
Medication:
ciprofloxacin (Cipro)
Criteria 5: medications that should be avoided or have their dosage reduced with varying levels of kidney function in older adults. (Table 6)
CrCl (mL/min) at which action is required
<30
Rationale
Increased risk of CNS effects (e.g., seizures, confusion) and tendon ruPture.
Recommendation
Dosages used to treat common infections typically require reduction when CrCl <30 mL/min.
Quality of evidence: Moderate, Strength of Recommendation: Strong
Last updated: Sep. 18, 2025
Renal Adjustment Policy ciprofloxacin subject to adjustments by pharmacy.
(Brand)
• Indications
Comments
(Cipro©)
q8h for pseudomonas
CrCl <30: 200-400 mg q24h
HD/PD: 200-400 mg q24h
(Cipro©)
CrCl 30-50: 250-500 mg q12h
CrCl <30: 500 mg q24h
HD/PD: 250-500 mg q24h
(Brand)
(Cipro)
(max: 400 mg/dose or
40 mg/kg/day)
(max: 750 mg/dose or
40 mg/kg/day)
(Brand)
(Cipro)